Sophia Genetics SA
SOPH
View Detailed Chart
3.320USD
+0.130+4.08%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
224.36MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.08%
5 Days
+6.41%
1 Month
-5.41%
6 Months
+10.67%
Year to Date
+8.14%
1 Year
-21.51%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-19Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Buy
Current Rating
7.000
Target Price
+119.44%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.03% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.17M.
Fairly Valued
The company’s latest PE is -3.02, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.69M shares, decreasing 0.54% quarter-over-quarter.
Held by Al Gore
Star Investor Al Gore holds 6.79M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
Ticker SymbolSOPH
CompanySophia Genetics SA
CEODr. Jurgi Camblong, Ph.D.
Websitehttps://www.sophiagenetics.com/
Related Instruments
+1.86%
+4.06%
+3.06%
-1.05%
+4.52%
+1.41%
-0.42%
+1.22%
+1.15%
+2.32%
-1.25%
-0.27%
+3.21%
-0.11%
+3.98%
+0.05%
-0.86%
+1.47%
+1.09%
+0.44%
